Fusion	Source	Drug	Drug Type	Cancer Type	Level	Direction	Link
EML4_ALK	CiViC	Crizotinib	ALK Inhibitor	Lung Cancer	A	Responsive	-
PCM1_JAK2	OncoKb	Ruxolitinib	JAK Inhibitor	Leukemia	B	Responsive	-